Histologies for all conclusive lesions in the eccentric and adjacent groups
| Overall | Forceps biopsy | Cryobiopsy | |
| Conclusive histology | 38 (58.5) | 20 (48.8) | 18 (75.0) |
| Malignant | |||
| Adenocarcinoma lung | 17 (44.8) | 9 (45.0) | 8 (44.4) |
| Squamous cell carcinoma | 4 (10.5) | 3 (15.0) | 1 (5.6) |
| Metastatic sarcoma | 1 (2.6) | 1 (5.0) | 0 (0.0) |
| Benign | |||
| Nodular lymphoid hyperplasia | 1 (2.6) | 0 (0.0) | 1 (5.6) |
| Infection | |||
| Tuberculosis | |||
| Granulomatous inflammation | 9 (23.8) | 3 (15.0) | 6 (33.3) |
| Necrotic tissue with guide sheath positive for Xpert MTB/RIF | 1 (2.6) | 1 (5.0) | 0 (0.0) |
| Chronic inflammation with therapeutic response to antituberculous drug | 4 (10.5) | 2 (10.0) | 2 (11.1) |
| Chronic inflammation with guide sheath culture positive for Penicillium | 1 (2.6) | 1 (5.0) | 0 (0.0) |
| Inconclusive histology | 27 (41.5) | 21 (51.2) | 6 (25.0) |
| Nondiagnostic | |||
| Bronchial epithelium | 13 (48.2) | 12 (57.2) | 1 (16.7) |
| Chronic inflammation | 5 (18.5) | 3 (14.2) | 2 (33.2) |
| Fibrotic alveolar septa | 2 (7.4) | 1 (4.8) | 1 (16.7) |
| Necrotic tissue | 2 (7.4) | 1 (4.8) | 1 (16.7) |
| Fibrocollagenous tissue | 1 (3.7) | 1 (4.8) | 0 (0.0) |
| Haemorrhagic lung tissue | 3 (11.1) | 3 (14.2) | 0 (0.0) |
| Entrapped gland | 1 (3.7) | 0 (0.0) | 1 (16.7) |
Data are presented as n (%), unless otherwise stated. n=65.